24 May 2013
Keywords: delavirdine, filed, usa, nnrti, role, reviewed, pharmacia
Article | 29 July 1996
Pharmacia & Upjohn has filed its New Drug Application in the USA for
Rescriptor (delavirdine) a non-nucleoside reverse transcriptase
inhibitor, for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 July 1996
© 2013 thepharmaletter.com